Heart Disease Clinical Trials in Chicago

Showing 61-80 of 257 trials

Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

NCT05719714

The goal of this study is to better understand the effects of a sodium-glucose transport protein 2 inhibitor, dapagliflozin, added on to standard of care on heart and lung function and circulating metabolites (substances created when our bodies break down food, drugs, or its own tissues) in patients with chronic kidney disease.

Chronic Kidney DiseasesHeart Failure With Preserved Ejection FractionKidney Diseases+1 more

Northwestern University60 participantsStarted Jan 2024

Chicago, Illinois, United States

ACTIVE_NOT_RECRUITINGPHASE32.2 miles

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

NCT05882045

The main purpose of this study is to evaluate the efficacy and safety of retatrutide once weekly in participants with obesity and established cardiovascular disease (CVD). The study will last about 113 weeks.

ObesityCardiovascular Diseases

Eli Lilly and Company1,800 participantsStarted May 2023

Phoenix, Arizona, United States • Covina, California, United States • Fresno, California, United States +166 more locations

Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease

A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease

Heart Disease Trials in Other Cities

Hybrid Coronary Revascularization Trial

Watermelon Dose Response Blood Pressure Study

Conduction System Pacing Optimized Therapy

Preventative Screening and Health Coaching in a Food Insecure Population

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

The Fluoroless-CSP Trial Using Electroanatomic Mapping

FUnctional diagnoSIs of corONary Stenosis (FUSION)

Interpersonal Relationships Intervention and Cardiovascular Health

Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD

SYMPHONY-PE Study for Treatment of Pulmonary Embolism

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

AB-1002 in Patients With Class III Heart Failure

Global Utilization And Registry Database for Improved heArt preservatioN

Virtual Care to Improve Heart Failure Outcomes (VITAL-HF)

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

Effect of Fetal Aortic Valvuloplasty on Outcomes

A Study to Evaluate the Safety of mRNA-0184 in Participants With Heart Failure

Other Conditions in Chicago